98%
921
2 minutes
20
Determination of the transcription level of cellular prion protein (PrP(C)) is essential for understanding its role in organisms and revealing mechanism of susceptibility and resistance to scrapie. However, the expression of prion protein (PrP) mRNA in sheep has not been quantified in great detail in digestive tract which is important during scrapie spread through oral route. Herein, we report on measurement of sheep PrP mRNA using absolute quantitative real-time RT-PCR. Total RNA was isolated from five different regions of the central nervous system (CNS), four regions of lymphoid system, eleven regions of digestive tract, and two reproductive organ tissues of eight sheep of two different genotypes (ARR/ARQ and ARH/ARQ) and PrP mRNA was quantified by real-time RT-PCR using molecular beacon. The results showed that highest levels of PrP mRNA were expressed in thalamus and cerebrum (P < 0.01) of CNS examined, followed by cerebellum, spinal cord, and brain stem. In peripheral organs examined, lymph tissue showed moderate level of PrP expression similar to that in digestive tract and reproduction organs. PrP expression levels in the same tissue of different genotype sheep had significant variation. Our study provided the first detail, tissue-specific and genotype-specific data of PrP mRNA expression in sheep for further studies of pathogenesis of prion diseases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11262-011-0579-7 | DOI Listing |
FASEB J
September 2025
Department of Pharmacy, College of Pharmacy, and Institute of Pharmaceutical Science & Technology, Hanyang University ERICA, Ansan, Republic of Korea.
Cellular prion protein (PrP) is a glycoprotein tethered to the plasma membrane via a GPI-anchor, and it plays a crucial role in prion diseases by undergoing conformational change to PrP. To generate a knock-in (KI) mouse model expressing bank vole PrP (BVPrP), a KI targeting construct was designed. However, a Prnp gene sequence that encodes PrP lacking seven C-terminal amino acid residues of the GPI-anchoring signal sequence (GPI-SS) was unintentionally introduced into the construct.
View Article and Find Full Text PDFStem Cell Res Ther
September 2025
Department of Translational Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
Background: Enhancing mesenchymal stem cells (MSCs) engraftment at the degenerative cartilage is important to increase the therapeutic effect of cartilage regeneration. Platelet-rich plasma (PRP) is known to have anti-inflammatory and anabolic effects for the treatment of osteoarthritis and has been reported to be commonly used with MSCs. However, little is known about the effects of PRP on MSCs adhesion to cartilage extracellular matrix (ECM).
View Article and Find Full Text PDFPlatelets
December 2025
Department of Pharmacology and Pharmacogenomics Research Center, College of Medicine, Inje University, Busan, Korea.
Background: UDP-glucuronosyl transferases (UGTs) are major enzymes of phase II drug metabolism, yet their expression in human platelets remains underexplored. Objectives: This study aimed to characterize the mRNA expression profile of UGT isoforms in human platelets and to assess differences between cigarette smokers and nonsmokers.
Methods: Total RNA was extracted from platelet-rich plasma (PRP), buffy coat (BC), and liver samples.
IUBMB Life
July 2025
Department of Orthopedics, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Bone defects present significant clinical challenges due to their morphological heterogeneity and structural complexity, necessitating regenerative strategies that integrate structural adaptability, biomechanical stability, and osteogenic potential. In this study, a bioengineered construct composed of bone marrow mesenchymal stem cells (BMSCs), platelet-rich plasma (PRP), polycaprolactone (PCL), and β-tricalcium phosphate (β-TCP) was fabricated using 3D bioprinting. In vitro assays assessed osteoprogenitor cell proliferation (CCK-8), migration (Transwell), differentiation (ALP staining), and endothelial tubulogenesis (Matrigel assay).
View Article and Find Full Text PDFPharmacol Res Perspect
August 2025
Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
CYP2A6 is the hepatic enzyme responsible for the metabolic inactivation of nicotine. Variation in CYP2A6 alters nicotine clearance, affecting numerous smoking behaviors and tobacco-related diseases, making investigating sources of variation important. A published molecular study of microRNA-126-5p, the microRNA-126 functional arm, showed it decreased CYP2A6 expression post-transcriptionally; it also showed that higher CYP2A7 mRNA competed for microRNA-126-5p binding, mitigating the CYP2A6 reduction.
View Article and Find Full Text PDF